TITLE

Screening, early neonatal diagnosis and prenatal diagnosis

AUTHOR(S)
Kuzemko, J. A.
PUB. DATE
January 1986
SOURCE
Journal of the Royal Society of Medicine (Supplement);Jan1986, Vol. 79 Issue 12, p2
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on studies of cystic fibrosis (CF), which may be of importance in diagnosis, carrier detection and molecular pathology. The methods used in carrier detection for CF are shown, including arginine esterase deficiency and sodium accumulation abnormality. It also discusses the use of amniotic fluid cells in establishing the diagnosis of CF in fetus.
ACCESSION #
23996700

 

Related Articles

  • Neutrophil necrosis and annexin 1 degradation associated with airway inflammation in lung transplant recipients with cystic fibrosis. Tsao, Francis H. C.; Zhuzai Xiang; Abbasi, Adnan; Meyer, Keith C. // BMC Pulmonary Medicine;2012, Vol. 12 Issue 1, p44 

    Background: Neutrophils sequestered in lower respiratory tract secretions in the inflamed lung may undergo apoptosis and/or necrosis and release toxic cellular contents that can injure airways or parenchyma. This study examined the viability of neutrophils retrieved from the proximal airways of...

  • Simple test screens genetics disease. Anderson, Ian // New Scientist;10/26/91, Vol. 132 Issue 1792, p25 

    Describes the QUT process, a test that could speed up the mass screening of large numbers of people on genetic diseases such as cystic fibrosis and sickle cell anemia. Identification of carriers of genetic diseases; Capability of the process to identify several variants of hemophilia and other...

  • Standards for clinical use of genetic variants.  // Nature Genetics;Feb2014, Vol. 46 Issue 2, p93 

    An introduction is presented in which the editor discusses various articles within the issue on topics including cystic fibrosis mutation database mutations, identifying mutations that impair the genome's ability to repair its DNA sequence, and statistical model for genetic disorders.

  • Newborn Screening for Cystic Fibrosis: Parents’ Preferences Regarding Counseling At the Time of Infants’ Sweat Test. Audrey Tluczek; Rebecca Koscik; Peggy Modaff; Darci Pfeil; Michael Rock; Philip Farrell; Caroline Lifchez; Mary Freeman; William Gershan; Christina Zaleski; Bradley Sullivan // Journal of Genetic Counseling;Aug2006, Vol. 15 Issue 4, p277 

    Newborn screening (NBS) protocols for cystic fibrosis (CF) are the first regional population-based programs to incorporate DNA analysis into their procedures. Research about these programs can inform policy and practice regarding how best to counsel families...

  • An overview of the management of cystic fibrosis. Littlewood, J. M. // Journal of the Royal Society of Medicine (Supplement);Jan1986, Vol. 79 Issue 12, p55 

    The article discusses the management of cystic fibrosis (CF). The use sweat for electrolyte analysis is described. Guidelines for establishing a correct diagnosis are listed, including the administration of two positive sweat tests. The availability of antibiotics effective against respiratory...

  • Evidence based guidelines for the performance of the sweat test for the investigation of cystic fibrosis in the UK. Baumer J H // Archives of Disease in Childhood;Dec2003, Vol. 88 Issue 12, p1126 

    A well produced evidence based guideline has been developed in response to a national audit that demonstrated wide variations in the performance of sweat tests. Accurate and reliable sweat test results will be particularly important with the advent of neonatal screening. The guideline...

  • Characterization of cystic fibrosis conductance transmembrane regulator gene mutations and IVS8 poly(T) variants in Portuguese patients with congenital absence of the vas deferens. Ana Grangeia; Florence Niel; Filipa Carvalho; Susana Fernandes; Azarnouche Ardalan; Emmanuelle Girodon; Joaquina Silva; Luis Ferrs; Mrio Sousa; Alberto Barros // Human Reproduction;Nov2004, Vol. 19 Issue 11, p2502 

    BACKGROUND: Cystic fibrosis conductance transmembrane regulator (CFTR) gene mutations and IVS8 poly(T) variants in Portuguese patients with bilateral (CBAVD) and unilateral (CUAVD) congenital absence of the vas deferens remain to be evaluated. METHODS: Patient screening was carried out by PCR,...

  • Nanoduct sweat testing for rapid diagnosis in newborns, infants and children with cystic fibrosis. Desax, Marie-Claire; Ammann, Roland A.; Hammer, Jürg; Schoeni, Martin H.; Barben, Jürg; Hammer, Jürg; Barben, Jürg; Swiss Paediatric Respiratory Research Group // European Journal of Pediatrics;Mar2008, Vol. 167 Issue 3, p299 

    Determination of chloride concentration in sweat is the current diagnostic gold standard for Cystic Fibrosis (CF). Nanoduct is a new analyzing system measuring conductivity which requires only 3 microliters of sweat and gives results within 30 minutes. The aim of the study was to evaluate the...

  • Detection of cystic fibrosis. Tárnoky, A. L. // Journal of the Royal Society of Medicine;Jan1980, Vol. 73 Issue 1, p73 

    The article discusses the diagnosis of cystic fibrosis (CF) by isoelectric. Diagnosis of CF depends on laboratory methods. The importance of the tests include clinically manifest cases, prenatal detection, recognition of carriers in CF kindreds and population screening. The results are valid...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics